These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Improving the detection of familial hypercholesterolaemia. Lan NSR, Martin AC, Brett T, Watts GF, Bell DA. Pathology; 2019 Feb; 51(2):213-221. PubMed ID: 30579649 [Abstract] [Full Text] [Related]
6. The management of familial hypercholesterolaemia in Morocco. El Messal M, Aït Chihab K, Chater R, Loutfi M, Kettani A, Hafidi A, Adlouni A. Acta Cardiol; 2006 Oct; 61(5):551-5. PubMed ID: 17117756 [Abstract] [Full Text] [Related]
10. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population. Radovica-Spalvina I, Latkovskis G, Silamikelis I, Fridmanis D, Elbere I, Ventins K, Ozola G, Erglis A, Klovins J. BMC Med Genet; 2015 Sep 28; 16():86. PubMed ID: 26415676 [Abstract] [Full Text] [Related]
11. Genetic analysis of familial hypercholesterolaemia in Western Australia. Hooper AJ, Nguyen LT, Burnett JR, Bates TR, Bell DA, Redgrave TG, Watts GF, van Bockxmeer FM. Atherosclerosis; 2012 Oct 28; 224(2):430-4. PubMed ID: 22883975 [Abstract] [Full Text] [Related]
13. Familial Hypercholesterolaemia in the Era of Genetic Testing. Hughes DP, Viljoen A, Wierzbicki AS. Curr Cardiol Rep; 2016 May 28; 18(5):42. PubMed ID: 27002618 [Abstract] [Full Text] [Related]
14. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways. Cameron J, Bogsrud MP, Tveten K, Strøm TB, Holven K, Berge KE, Leren TP. Transl Res; 2012 Aug 28; 160(2):125-30. PubMed ID: 22683370 [Abstract] [Full Text] [Related]